Announced Mon, 29 Sept · 16:01 IST

Proceedings of 51st Annual General Meeting of the Company held on 29th September 2025 pursuant to Regulation 30 of SEBI (LODR) Regulations

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sunil Healthcare Ltd held its 51st AGM on September 29, 2025 via video conferencing, starting at 12:45 PM and concluding at 1:04 PM. Chairman and Managing Director Mr. Anil Kumar Khaitan presided over the meeting along with 5 other directors, the CFO, President, and the Secretarial Auditor. The Chairman noted that FY2024-25 was challenging due to rising raw material costs, a stronger US dollar, the ongoing Russia-Ukraine war, and subdued demand, but said the company improved its EBITDA, PBT, and PAT through cost control and efficiency measures in its empty hard capsules business. Three ordinary resolutions were tabled: adoption of audited financial statements for FY ending March 31, 2025, re-appointment of Mr. K.V. Rajan as Non-Executive Director, and appointment of M/s ATCS & Associates as Secretarial Auditors for a 5-year term (FY2025-26 to FY2029-30). The auditors' report carried no qualifications or adverse remarks, and voting results (remote e-voting + insta poll) will be announced within 2 working days.

Likely market impact

No material strategic announcement was made at this AGM — it was a procedural meeting covering standard items like financial statement adoption, director re-appointment, and auditor appointment. Shareholders should watch for the voting results (expected within 2 days) for confirmation of resolution approvals. The chairman's commentary suggests FY2024-25 was a tough year but margins improved, with management guiding for better performance ahead.